Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1: Literature Update Period: July 2020 through September 2021

Excerpt

This report is the first update for the Agency for Healthcare Research and Quality (AHRQ) 2020 report Acute Treatments for Episodic Migraine (available at https://effectivehealthcare.ahrq.gov/products/migraine-treatments/research) and covers the time period from July 2020 through September 2021. The original 2020 report examined the evidence on the comparative effectiveness and harms of opioids as well as nonopioid pharmacologic and nonpharmacologic treatments to provide the full range of evidence to inform clinical decision making about the acute treatment of migraine.

The objective of this update is to identify the latest evidence published since the 2020 report and to determine how the new evidence impacts the findings of the 2020 report. Subsequent updates are planned for March 2022 (based on evidence published from October to December 2021) and June 2022 (based on evidence published from January to March 2022).